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Mode of action
Peptide–membrane interactionRibosomally synthesized antimicrobial peptides (AMPs) represent an essential component of the ancient and
non-speciﬁc innate immune system in all forms of life, with the primary role of killing infectious
microorganisms. Amphibian skin is one of the richest storehouses for them. Each frog species produces its
own set of peptides with up to 10 isoforms, as in the case of the species Rana temporaria. Nowadays, human
health is facing two major threats: (i) the increasing emergence of resistant pathogens to one or more
available drugs, and (ii) the onset of septic shock, which is associated with the release of lipopolysaccharide
(LPS) from the cell walls of Gram-negative bacteria, particularly upon antibiotic treatment. AMPs are
considered as potential new anti-infective compounds with a novel mode of action, because many of them
can kill bacteria and, at the same time, neutralize the toxic effects of LPS. Recent studies have suggested that
the production of large number of structurally similar AMPs within the same animal is a strategy used by
nature to increase the spectrum of antimicrobial activities, by using combinations of the peptide's isoforms.
The biological rationale for their coexistence within the same organism is discussed. In addition, the
distinctive and attractive synergistic effects of temporins in both antimicrobial and anti-endotoxin activities
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ll rights reserved.1. Amphibian antimicrobial peptides — discovery and function
The amphibian skin is one of the richest sources of biologically active
peptides displaying pharmacological as well as antimicrobial properties
[1–4]. Antimicrobial peptides (AMPs) represent the major component,
with sizes ranging from 10 to 46 amino acid residues and constitute the
Table 1
Primary structure of some temporins.
Basic and acidic residues are indicated by red and blue letters, respectively. Gaps (-)
are inserted to maximize identities. The species names of frogs and peptides'
abbreviations reﬂect the new nomenclature proposed by J.M. Conlon [25].The
sequence of temporins ALa, 1ARa, 1AUa, 1BYa, 1Ca/Cb, 1Ec, 1Ga/Gb, GH, 1HKa/
1OLa/1OLb, 1Ja, 1Oa/Od, 1PLa, 1PRa, 1SPa/SPb, 1TGa, 1Va, 1Vb are reported in
references [87], [88], [89], [90], [91], [92], [93], [94], [95], [96], [97], [98], [99], [100],
[101], [102], [103], respectively.
Fig. 1. (a) Schematic representation of the precursors encoding for temporins. C and KR
indicate the highly conserved amino acid residues ending the pre- and pro-peptide
sequence, respectively. The G residue ﬂanking the C-terminus of the mature peptide
serves as its amide donor. (b) Nucleotide sequence and deduced primary structure of
the pre–pro-peptide of temporin-1Tb [20]. The sequence of the mature peptide is
underlined in red; in black the polyadenylation site at the 3′-end. Vertical arrow
denotes the probable site of cleavage by the signal peptidase.
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dermal glands and released into the skin secretion, in a holocrine
manner, upon stress or injury, as a result of contraction of myocytes
surrounding the glands [3]. All together, frog skin represents a good
model system to investigate the in vivo role of AMPs in vertebrates [6],
and various reports have highlighted their functional importance inhost
protection against pathogenic microorganisms [7,8]. All frog species are
endowedwith their own unique set of AMPs, constituting families of 2–
100 closely related members [9] (see also the review of J.M. Conlon, the
same issue), but very little is known about the biological signiﬁcance of
multiple forms of a prototypic peptide sequence within the same
organism. The principal classes of structurally similar amphibian AMPs
encompass bombinins and bombinins H from the European toads
Bombina variegata and Bombina orientalis [10–13] (see also a chapter in
this issue); magainins from the African clawed frog Xenopus laevis [14],
dermaseptins, originally isolated from the South American arboreal frog
Phyllomedusa sauvagii [15,16], and those from the Rana genus (e.g.,
brevinins, ranalexins, ranatuerins, esculentins and temporins) [17–21].
Recent studies have demonstrated that several amphibian AMPs
synergize with each other in the antimicrobial activity [7,22,23]. This
review summarizes relevant details in these studies and shows how
nature provided each animal with a speciﬁc and fast-acting defence
system that also allows synergism between several peptide combina-tions. More speciﬁcally, this review focuses on the unique synergistic
effects of some temporins (1Ta, 1Tb and 1Tl) in inhibiting both Gram-
negative bacterial growth and the toxic effect of lipopolysaccharide
(LPS). Besides their scientiﬁc importance, studies along this line should
open additional avenues for the design of new anti-infective AMPs.
2. Temporins
2.1. Biosynthesis and structural characterization
Temporin-like peptideswere initially identiﬁed inmethanol extracts
of the skins of the Asian frog Rana erythraea and the European hybrid
frog Rana esculenta [24] (reclassiﬁed as Pelophylax lessonae/ridibundus
[25]). They were described as Vespa-like peptides, because of their
sequence similarity to chemotactic peptides isolated from the venom of
wasps of genus Vespa [26]. Afterwards, in 1996, 10 structurally related
peptides, endowed with antimicrobial properties, were discovered by
Simmaco et al. [20]. They were isolated from skin secretions of mild-
electrically stimulated specimens of the European red frog Rana
temporaria and were properly designated as temporins, from A to L
[(now re-named temporins 1Ta–1Tl, according to the new nomencla-
ture proposed by J.M. Conlon [25], see Table 1)]. New members were
then identiﬁed in skin secretions of other ranid frogs of both North
American and Eurasian origin (Table 1), enlarging temporin family to
more than 100 different isoforms [9]. Although someof them contain up
to 17 amino acids, temporins are among the smallest AMPs (10–14
residues long) found in nature to-date and with a low net positive
charge at neutral pH (0 to +3), due to the presence of only 1 or 2 basic
residues in their sequence. This lowcationic character is unique for them
and is an exception compared to known AMPs from other sources.
Temporins are synthesized as precursors (Fig. 1) bearing a strictly
conserved N-terminal domain and an acidic propiece ending with the
pair Lys-Arg [20]. These structural features are similar to thosepresent in
the precursors of other AMPs from the Rana genus [18,27] and the
Phyllomedusinae subfamily [28]. A single copy of the mature peptide is
located at the C-terminus of the acidic prosequence, and a Gly residue,
which ﬂanks the carboxyl-terminus of the mature peptide, serves as its
Fig. 2. Scanning electron microscopy of temporin-1Tl-treated E. coli D21. (a) Control
bacteria; (b) bacteria after peptide treatment for 15 min at a lethal concentration
(50 μM with 1×107 cells). Each ﬁgure has been magniﬁed × 15,000. A prominent
collapse of the cell structure and a deep roughening of the cell surface are visible after
microbial exposure to the peptide.
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C-terminal heptapeptide ring, stabilized by a disulphide bridge,
temporins are amidated at their carboxyl end (Table 1), as a result of a
post-translational enzymatic reaction, where the penultimate Gly
residue in the pro-peptide (Fig. 1) acts as a substrate for peptidyl-
glycine α-amidating monooxygenase [29].
2.2. Target cell selectivity
Functional studies have pointed out that despite their small size
and low net positive charge (+2 for most isoforms), temporins act
efﬁciently and rapidly against Gram-positive bacteria, including
clinical isolates that are resistant to conventional antibiotics (see the
review of J.M. Conlon, the same issue). Their Minimal Inhibitory
Concentration (MIC) ranges from 2.5 to 20 μM [9,30]. Interestingly,
other isoforms with similar sequences, namely, temporin-1Tl and
temporin-1Dra from R. temporaria and Rana draytonii, respectively,
are highly active also against Gram-negative bacteria, fungi, and
erythrocytes [31,32]. Furthermore, protozoa and viruses have been
reported to be targets of this family of AMPs. Indeed, temporins-1Ta
and 1Tb from R. temporaria and temporin-1Sa from the North African
ranid Pelophylax saharica [33,34] exert potent antiparasitic activity, in
vitro, on promastigotes (insect stage) and amastigotes (mammalian
stage) of Leishmania genus. In particular: (i) the isoforms Ta and Tb
induce complete inhibition of viability of Leishmania donovani and L.
pifanoi (causing the visceral and cutaneous leishmaniasis, respec-
tively), with severe damage to the plasma membrane [35]; (ii)
temporin-1Sa displays an antiparasitic effect (IC50∼20 μM) on
promastigotes and axenic amastigotes of Leishmania infantum [33].
Temporin-1Ta also reduces the infectivity of channel catﬁsh virus and
frog virus 3 [36].
Noteworthy to recall that in addition to antimicrobial and antiviral
properties, a signiﬁcant number of amphibian AMPs were shown to
have selective cytotoxic activity against neoplastic cells [37]. In
addition to temporin-1Tl, which is active on human erythroleukaemic
and human cutaneous T lymphoma cells, other small-sized AMPs from
frog skin have been found to display a lytic effect on tumor cells.
Among these, the aurein 1.2 (13 residues long) from the Australian
bell frog Litoria raniformis [38]; the citropin 1.1 (16 residues long) from
the tree frog Litoria citropa, [39]; some members of the gaegurin
family [40]; magainins, from the African toad X. laevis and their
derivatives [41].
The molecular mechanism governing cell selectivity of temporins,
as well as of many other AMPs, is not clear. However, recent studies
have suggested that cell speciﬁcity is dictated by both physico-
chemical characteristics of a peptide (sequence, charge distribution,
oligomeric state, amphipathicity and helicity), and by the type of the
target cell surface and its metabolism. Cell speciﬁcity can also be
controlled by combinations of AMPs, as will be outlined below, for
temporins-1Ta, Tb and Tl.
3. Temporins-1Ta, Tb and Tl
The isoform temporins-1Ta, 1Tb and 1Tl from R. temporaria skin
secretion are among the most studied temporin peptides for their
mechanism of action on both intact bacteria and artiﬁcial systems.
3.1. Mode of action on intact bacteria
Regardless of the precise mode of action, the effect of AMPs in
general depends upon their interaction with the microbial membrane
[42]. The ﬁrst step in this interaction is the electrostatic attraction
between the cationic peptide and the negatively charged components
of the cell envelope. These include the phosphate groups within the
LPS in the outer membrane (OM) of Gram-negative bacteria, or the
lipoteichoic acid (LTA) on the surface of Gram-positive bacteria. Theinner leaﬂet of the OM in Gram-negative bacteria is composed of
phospholipids resembling those of the cytoplasmic membrane,
whereas the outer leaﬂet contains mostly LPS, which encompasses
three parts: (i) a lipid A region consisting of a disaccharide of
phosphorylated glucosamines attached to six or seven saturated fatty
acids chains, some of which are hydroxylated; ii) a hydrophilic O-
antigenic domain, made of repeating saccharide units, varying among
different bacterial species, which protrude into the surrounding
medium [43,44]; and (iii) an oligosaccharide core, which connects
the two portions.
Initially, AMPs traverse the LPS layer in a self-promoted uptake
process driven by hydrophobic interactions [42], and subsequently
reach the cytoplasmic inner membrane (IM). With regard to
temporins, most studies have revealed that the killing process is
rapid and concomitant with the permeation of the IM [9,35].
Furthermore, differing from those AMPs that interfere with intracel-
lular functions without destabilizing the bacterial membrane, tem-
porin-1Tl, for example, perturbs the membrane even at
concentrations that are signiﬁcantly lower than the MIC [45].
However, in contrast with many natural and de novo designed
AMPs, temporin-1Tl does not lyse bacteria, but rather causes them a
ghost-like shape with a deep roughening of their surface and a
collapse of the cellular structure (Fig. 2).
3.2. Conformation and orientation within model membranes
Mostof the temporins, like otherAMPsderived from frog skin, adopt
mainly a randomcoil conformation in aqueous solution.However, there
are exceptions such as the isoform Tl, which adopts an α-helical
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the majority of AMPs, temporins form an amphipathic structure in a
biological membrane or in a membrane-mimetic environment. In this
context, temporins-1Ta and Tl have been analyzed by spectroscopic
techniques (CD and NMR) and molecular dynamics simulation, in the
presence of sodium dodecyl sulfate (SDS) and dodecylphosphocholine
(DPC) micelles, mimicking the negatively charged and zwitterionic
membranes, respectively. In SDS, the peptides are located at the
micelle-water interface, whereas in DPC, they prefer a location
perpendicular to the micellar surface, with the N-terminus embedded
in the hydrophobic core. However, there are discrepancies between the
twopeptides: temporinTl has a higher propensity, comparedwithTa, to
form α-helical structures in both membrane-mimetic systems, as well
as a higher propensity to penetrate the lipid vesicles.
The loss of α-helical structure along the entire sequence of
temporin-1Ta in DPC (Fig. 3a), correlates with the peptide's inability
to deeply insert into the hydrophobic core of this type of vesicles,which
canbe the reason for theweak lytic effect of Ta on red blood cells. Such a
result is in contrast with the strong haemolytic activity of Tl and its
profound penetration into DPC micelles, where the α-helicity of the
peptide extends from the N- to the C-terminal amino acid (Fig. 3a). In
SDS micelles, both temporins prefer a distribution at the lipid-water
interface, parallel to the micellar surface (as also found for the
temporins from P. saharica [34]). In addition, they have a lower
tendency to form an α-helical structure: in Ta, it encompasses the
central residues 6–9, and in Tl, residues 3–11 (Fig. 3b). Studies on their
topological orientation suggest the formation of a “dynamic peptide-
lipid supramolecular complex”. Based on this, the peptide could bind
the negatively charged lipids and form transient pores that increase in
size as the peptide-to-lipid molar ratio also increases [46]. When the
peptide-to-lipid ratio is very high, this results in detergent-type
micellization of themembrane, as described by the “carpet”model [47].Fig. 3. Structure of temporins-1Ta and Tl in DPC (a) and SDS (b)micelles, as determined by NM
a ribbon. Heavy atoms are shown with different colours (carbon, green; nitrogen, blue; ox
activities of the temporins are schematized inside boxes. The red and blue colours of the peA possible explanation for the different orientations of temporins
in DPC versus SDS may relate to the balance between the net
positive charge and the hydrophobicity of a particular peptide.
Analogs with high hydrophobicity can bind electrostatically to the
negatively charged head groups of SDS and would be kept on the
surface. However, in zwitterionic DPC they will have sufﬁcient
hydrophobicity that will allow them to penetrate into the hydro-
phobic core of the micelles. In contrast, peptides with low
hydrophobicity, will bind electrostatically to the surface of SDS,
and will not have sufﬁcient hydrophobicity to penetrate into the DPC
micelles.
Overall, our data led to the assignment of different molecular
mechanisms underlying the antimicrobial and haemolytic activities of
these temporins [46]: a “carpet” mechanism and the formation of a
“barrel-stave” pore in negatively charged and zwitterionic mem-
branes, respectively (Fig. 3). Interestingly, a general “carpet-like”
mode of interaction of AMPs when bound to negatively charged
membranes has been reported. According to this mechanism, the
peptides are located ﬁrst on the surface of phospholipid bilayers until
a local threshold concentration has been reached, which further lead
to the formation of local defects in them [47]. The list of these AMPs
includes cathelicidin LL-37 [48]; the granulysin [49]; the tachyplesin
[50] and polyphemusin [51].
Note that temporins are too short (only 13 amino acids) to span the
entire membrane and to act via the “barrel-stave” mechanism in
zwitterionic membranes. This implies that they might form dimers
head-to-tail or via other orientations; however, this hypothesis needs
to be further investigated.
Although temporins differ frommost cationic AMPs by having only
1–2 positively charged amino acids, they are able to disrupt anionic
membranes to a similar extent of that of most highly positively
charged AMPs, the reason for which is yet not known.R studies [46]. The backbone of the lowest energy structure in each peptide is shown as
ygen, red). The molecular mechanisms proposed for the haemolytic and antibacterial
ptide (cylinder) indicate its hydrophilic and hydrophobic regions, respectively.
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The ﬁnding of a synergism between AMPs is not surprising,
considering the simultaneous presence of several isoforms within the
same animal. The occurrence of synergism was ﬁrst observed in the
dermaseptin family, where the antimicrobial action of combined
dermaseptins was higher than the sum of individual peptides [7]. As
indicated in the previous paragraphs, Gram-negative bacteria are
resistant to temporins-1Ta and Tb; however, a combination of each of
themwith a sub-inhibitory concentration of temporin-1Tl overcomes
resistance [52]. Surprisingly, this synergistic effect is more pro-
nounced against Aeromonas hydrophila, which is an opportunistic
pathogen living in healthy frogs, but can cause high mortality in
amphibian populations, leading to diseases such as the natural
outbreaks of “red leg” [8]. Note that this bacterium is not susceptible
to several AMPs from frog skins, e.g., magainin I, magainin II, PGLa,
ranalexin, and dermaseptin [8] and to several conventional antibiotics
[53]. In addition, in humans, this microbe is responsible for a variety of
infections (e.g., gastroenteritis), especially in immunocompromised
individuals [54,55]. These examples indicate that the production of a
large number of structurally similar AMPs, within a single frog species,
can protect the animal from awider range of microorganisms. Because
of the continuous growth of resistant clinical isolates to currently used
antibiotics, studies aimed at the development of strategies for the
production of new non-single-peptide-based antimicrobials are also
in progress. Nowadays, a number of AMPs reached the phase of clinical
evaluation and potential marketing as novel anti-infective compounds
[56]. Furthermore, the requirement of a lower concentration for each
component of the therapeutic formulationwould reduce the problems
associated with its production-cost and side effects on patients.
Importantly, antibiotic therapy against Gram-negative bacterial
infections is often accompanied by the release of LPS, also known as
endotoxin. The immune system has evolved to recognize LPS as a
pathogen-associatedmolecular pattern (PAMP). LPS is a potent inducer
of the innate immune system and is primarily responsible for lethalityFig. 4. (a) Fractional inhibitory concentration index (FIC) of temporins Ta+Tl, Tb+Tl and T
inhibitory concentration (FIC) index for combinations of two peptides is calculated accordin
and B are the MICs of drug A and drug B in the combination, MICA and MICB are the MICs o
number of wells per plate used to calculate the FIC. The FIC indices are interpreted as fo
antagonism. (b) Schematic representation of LPS molecules in different E. coli strains (D21
KDO, ketodeoxyoctonic acid; P, phosphate; E, ethanolamine; X, neutral sugar residue [80].in sepsis that afﬂicts about 600,000 individuals in the United States
alone, annually [57]. Upon its release, LPS is recognized bymononuclear
phagocytes (monocytes andmacrophages),which are part of the innate
immunity of the host, and it activates them. This enhances their
phagocytic activity and signiﬁcantly raises the secretion level of pro-
inﬂammatory cytokines, e.g. tumor necrosis factor alpha (TNF-α),
interleukin-6 (IL-6), and others [58–64]. Pro-inﬂammatory cytokine
production is essential for initiating the local inﬂammatory response.
However, an excess of LPS, resulting fromthe invasionofGram-negative
bacteria or as a consequence of intensive antimicrobial chemotherapy
[65,66], causes prolonged activation of the immune cells, with an
unbalanced systemic secretion of cytokines. This can rapidly give rise to
the onset of septic shock syndrome, characterized by endothelial
damage, loss of vascular tone, coagulopathy, fever, hypotension and
multiple organ failure, which, in extreme cases, leads to death [67,68].
An attractive strategy to combat sepsis is to develop compounds that
would sequester LPS, thereby blocking its interactions with the serum
and cellular receptors [69,70]. AMPs represent good candidates for this
purpose. Indeed, unlike classical antibiotics, several AMPs possess dual
functions: they kill bacteria and neutralize the effect(s) of LPS, although
the exactmechanism is not yetwell understood [52,71–73]. In linewith
this, a combination between AMPs and drugs, or two different AMPs,
may enhance antibacterial/anti-endotoxin activities and hamper the
emergence of resistance. The following paragraphs summarize recent
studies on the synergistic effects within two pairs of temporins (Ta+Tl
and Tb+Tl), in two functions: the growth inhibition of Gram-negative
bacteria and the neutralization of LPS-activated macrophages, along
with a plausible molecular mechanism.
4.1. Synergism between temporins in antimicrobial activity and the
underlying molecular mechanism
Members of the temporins family, namely, 1Ta and 1Tb, were
found to display a synergistic effect against Gram-negative bacteria,
when each was combined with temporin-1Tl (Fig. 4). Interestingly,a+Tb against the two Gram-negative strains E. coli O111:B4 and O26:B6. The fractional
g to the following equation:∑(FICA+FICB)/n,=∑(A/MICA+B/MICB)/n, where A
f drug A and drug B alone, FICA and FICB are the FICs of drug A and drug B, and n is the
llows [86]: FIC≤0.5, synergy; 0.5bFICb1, additivity; 1≤FICb4, indifference; FIC≥4,
e7, D21 f1, D21 f2 and O111:B4). Glc, glucose; Col, colitose; GlcN, N-acetylglucosamine;
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LPS-carbohydrate chains (e.g. Escherichia coli O111:B4) (Figs. 4 and 5),
but not with E. coli O26:B6, which has a shorter LPS-carbohydrate
region (Figs. 4 and 5), or with cell-wall defective mutant strains of E.
coli D21 (e.g., E. coli D21 e7; D21f1 and D21f2). The latter have lost
increasing amounts of sugar residues in their LPS backbone (Fig. 4).
Fluorescence spectroscopy was then used to elucidate the underlying
molecular mechanism and to verify whether the different behaviour
of Ta+Tl and Tb+Tl on E. coli O111:B4 and O26:B6 could reﬂect
different organization of the peptides, when in contact with the two
types of LPS. In this assay, rhodamine-labeled temporins (rho-temp)
were synthesized and examined for their interactionwith puriﬁed LPS
O111:B4 and O26:B6. When rhodamine-labeled monomers are self-
associated, the outcome is self-quenching of the emission ﬂuores-
cence. However, enzymatic digestion of the rhodamine-labeled
peptide should result in the recovery of ﬂuorescence, owing to the
dissociation of the oligomers. The addition of LPS to rho-temps Ta and
Tb induced a marked and dose-dependent quenching of ﬂuorescence,
revealing that both types of LPS triggered the oligomerization of the
two peptides [22]. These ﬁndings are in line with recent reports
revealing that self-assembly of AMPs causes a dramatic reduction in
their antimicrobial activity. This is because of the larger size of the
oligomers, compared to that of monomers, which prevents the
peptide to diffuse through the cell wall [52].
Differing from temporins-1Ta and Tb, an increase in ﬂuorescence
was manifested upon addition of LPS to rho-temp Tl, pointing out a
partial disaggregation of this peptide, regardless of the type of LPS
used. This should make it easier for temporin-1Tl to traverse the LPS
leaﬂet into the target IM [52], and is in agreement with its strong
activity on Gram-negative bacteria. Noteworthy, the data from the
ﬂuorescence studies ﬁt with the results obtained by circular dichroismFig. 5. The effect of unlabeled temporins on the ﬂuorescence of rho-temp Ta (upper panels)
and O111:B4 (right panels). The labeled peptides were incubated with the same concentra
(+Tl, ●). Once the ﬂuorescence reached a constant value, LPS was added (ﬁrst arrow, t=
plotted as arbitrary units. The rhodamine-labeled peptide-to-LPS molar ratio was 1:4. Th
Control (—) is given by the ﬂuorescent peptide without the addition of unlabeled temporins
respectively, are not reported, since they were similar to those shown when unlabeled temp
mixed with unlabeled Tl, a less ﬂuorescence quenching than that caused with unlabeled Ta
(left panels). The values represent the mean of triplicate samples with S.D. values not exceed
Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) of the two types of
indicated by the different molecular weight bands, LPS from E. coli O26:B6 has shorter polin LPS micelles, showing that only temporin-1Tl could adopt an α-
helical structure [22]. Since the hydrophobic environment of a
membrane induces an α-helix structure to amphipathic peptides,
the lack of helicity in Ta and Tb might be due to their binding to those
portions of LPS facing the solution, rather than to those in proximity
with the inner and more hydrophobic lipid moiety of LPS [22]. This is
because both Ta and Tb form oligomers that cannot penetrate easily
into the hydrophobic core of LPS.
The next stepwas to check the effect of unlabeled temporins on the
rhodamine-labeled isoforms, upon addition of LPS from both types of
bacteria. The presence of unlabeled temporins-1Ta or Tb did not affect
the ﬂuorescence quenching of the labeled peptides. In contrast, when
rho-temps Ta and Tb were mixed with unlabeled temporin Tl (Fig. 5),
a considerable lower quenching of ﬂuorescence was obtained after
contact with LPS O111:B4 (Fig. 5, right panels), but not with LPS O26:
B6 (Fig. 5, left panels). These results suggest that temporin-1Tl
hampers the self-association of Ta and Tb induced by LPS O111:B4 and
that this property is lost with LPS with a short sugar chain.
Overall, these studies have revealed two important ﬁndings:
(i) Temporins-1Ta and Tb are not active on Gram-negative
bacteria, because they oligomerize once bound to bacterial
LPS, which makes it hard for them to cross the OM and reach
the target cytoplasmic membrane.
(ii) The synergistic activity between temporins Ta+Tl and Tb+Tl
towards Gram-negative bacteria takes place on the OM, and is
related to the ability of Tl to prevent the self-association of Ta
and Tb, and hence to assist them to traverse the cell wall. Such a
statement is also supported by the loss of synergism against
both E. coli spheroplasts, which are devoid of a cell wall and
Gram-positive bacteria lacking the OM. Mechanistically, it isand rho-temp Tb (lower panels) in the presence of LPS from E. coli O26:B6 (left panels)
tion of unlabeled temporin-1Ta (+Ta, ■), temporin-1Tb (+Tb, ▴), and temporin-1Tl
0) and changes in ﬂuorescence were monitored (λexc=485 nm, λems=590 nm) and
e second arrow indicates the addition of proteinase-K (pk, 80 μg/ml) to all samples.
. The results obtained with unlabeled temporin-1Tb or Ta in the upper or lower panels
orin-1Ta or Tb was used instead, in the respective cases. When rho-temp Ta or Tb were
or Tb, was noted upon addition of LPS O111:B4 (right panels), but not with LPS O26:B6
ing 2% from a single experiment, representative of three different experiments [22,80].
LPS, using a gel containing 12% acrylamide and 0.5% SDS is reported in the middle. As
ysaccharide chains with respect to LPS O111:B4.
Fig. 6. The effect of temporins on TNF-α secretion by LPS-activated macrophages. RAW
264.7 macrophages were stimulated with LPS (10 ng/ml) derived from E. coli O111:B4
or O26:B6 in the presence of 2.5 μM temporins-1Ta, Tb and Tl alone or in combinations
of two (Ta+Tb, Ta+Tl or Tb+Tl, 2.5+2.5 μM). The percentage of inhibition of TNF-α
release was normalized to that of macrophages stimulated with LPS without peptides
(0% inhibition). The results are the average of three independent experiments; each
experiment was performed in duplicate. Error bars are standard deviations (taken from
Ref. [80]).
Fig. 7. Effect of temporins on the aggregation state of FITC-labeled LPS from E. coli O111:
B4 and O26:B6. LPS-FITC (2.5 μg/ml) treated with 1.5 μM temporin-1Ta, Tb or Tl and the
combination of temporins Ta+Tb, Ta+Tl and Tb+Tl (1.5 μM each peptide). The
change in FITC emission after each treatment wasmonitored until the ﬂuorescent signal
reached a constant value. The increase of ﬂuorescence reﬂected a change in the LPS-FITC
aggregation state. LPS-FITC increases its emission when the distance between its
monomers increases, because of dequenching. Standard error of the experimental
measurements is also indicated.
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diffuse more easily across the LPS leaﬂet. Alternatively,
temporin-1Tl could modify the structure of LPS molecules
and, as a consequence, inhibit the LPS-induced self-assembly of
Ta and Tb. Noteworthy, it has been found that the synergism of
temporins in overcoming bacterial resistance, owing to the LPS
barrier, is highly dependent on the length of the polysaccharide
region of this molecule. In particular, the disaggregation of the
two pairs of temporins, when in contact with the LPS-OM
should be hindered by a change in LPS ﬂuidity, which
diminishes as the polysaccharide region of LPS reduces its
length. This can be interpreted in part as a result of a lower
hydration and a lower amount of water molecules in a
disordered organization, around LPS with a short carbohydrate
region, such as LPS O26:B6. This would increase the rigidity of
the structure of this type of LPS to a higher extent than that of
LPS O111:B4 (which has longer sugar chains), so as to interfere
with the synergistic effect.
To date, only a few peptide combinations synergize in the
antimicrobial activity. These include isomers of dermaseptins [7],
magainin 2 and PGLa from X. laevis [74], the mammalian cathelicidins
and defensins [75], and the combination of hepcidin andmoronecidin,
from bass gill tissue [76]. Nevertheless, with the exception of
magainin-2/PGLa, the molecular basis accounting for their synergic
activity has not been addressed. Interestingly, the mechanism under-
lying the synergism between temporins differs from what has been
proposed for the pair magainin/PGLa [77]. In the latter case, it is
associated with an increasing perturbation of the cytoplasmic
membrane, because of increasing pore formation activity by the
heterodimermagainin/PGLa, which has a better pore-forming activity
than each peptide alone [78,79].
4.2. Synergism of temporins in LPS-detoxiﬁcation and the underlying
molecular mechanism
Temporins-1Ta, Tb, and Tl have been shown to neutralize the toxic
effect of LPS derived from various species of E. coli, by complexing
with it and making it unavailable for interaction with macrophage
receptors to stimulate TNF-α secretion (considered to be a primary
mediator of endotoxemia). In particular, this process was more
pronounced when macrophages were activated with LPS O26:B6
and treated with temporin-1Tl [80]. Most interestingly, the two
peptide combinations Ta+Tl and Tb+Tl exhibited a strong synergismin neutralizing LPS O26:B6, but not LPS O111:B4. Indeed, as illustrated
in Fig. 6, only when temporins Ta+Tl and Tb+Tl were added to LPS
O26:B6-stimulated macrophages, the inhibition of TNF-α release was
much greater than the corresponding additive effect of the single
peptides. According to what is indicated in the report, this seems to be
the ﬁrst case showing a marked synergism between AMPs from the
same specimen in the LPS-detoxiﬁcation. This event was accompanied
by disruption of LPS aggregates to smaller-size particles, as manifested
by quasi-elastic light scattering analysis [80]. Conversely, a different
distribution in size and polydispersity was noticed when LPS O26:B6
was treated with each peptide alone or with the combination Ta+Tb
[80]. This outcome is in agreement with the notion that one of the
requirements for temporins to neutralize LPS is linked to its capability
to reduce the aggregation state of LPS, probably by forming small
complexes between LPS and peptides, similarly to other AMPs [52]. To
further examine whether the LPS-detoxiﬁcation activity of single or
mixed temporins reﬂected their capacity to dissociate LPS micelles,
the effect of these peptides on FITC-LPS O111:B4 and FITC-LPS O26:B6
was also investigated. The ﬂuorescence of FITC-LPS aggregates is self-
quenched but increases when the aggregates disassemble, because of
dequenching [81]. All temporins disaggregated the structure of both
types of LPS (Fig. 7), but this effect was higher when Ta+Tl or Tb+Tl
were added to FITC-LPS O26:B6 (Fig. 7).
It is important to highlight that, when used alone, temporin-1Tl
was more potent in inhibiting LPS-induced activation of macrophages
[80], although its ability to dissociate LPS aggregates was weaker than
that of Ta and Tb (Fig. 7). This underscores that, besides alteration of
the LPS structure, additional processes (e.g., ability to achieve and
bind the toxic region of LPS, the lipid A) should be involved and crucial
for the endotoxin-neutralization activity of the peptide.
The changes in the LPS organization mentioned above would
expose additional peptide binding sites, otherwise hidden within the
LPS micelles, to make electrostatic interactions between peptides and
LPS molecules more favourable. This interpretation is consistent with
the exothermic nature of the binding reactions of temporins Ta+Tl
and Tb+Tl to LPS O26:B6 [80]. In comparison, when temporins were
added (either alone or in their combinations) to LPS O111:B4, an
exothermic binding reaction and an overall compactness of the LPS
structure was produced in all cases [80].
The synergistic effect of temporins in preventing the LPS activation
of macrophages relies on the capability of the two pairs of peptides to
Fig. 8. Left panels: Schematic illustration of the synergistic effect of temporin-1Ta (brown)+Tl (purple) in the antimicrobial activity against E. coli O111:B4 and not E. coli O26:B6.
Right panels: Schematic illustration of the non and synergistic effects of temporins-1Ta+Tl in the anti-endotoxin activity of LPS O111:B4 and O26:B6, respectively.
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each temporin alone.
This ﬁnding is favoured by (i) LPS having short carbohydrate side
chains, and (ii) peptide molecules folded in an oligomeric state. The
second issue matches very well with the knowledge that peptide
dimers can alter the structure of LPS more efﬁciently than the
respective single monomers [82].
Overall, the synergism of temporins in inhibiting TNF-α release
from LPS-treatedmacrophages is a speciﬁc phenomenon that depends
on the type of LPS and peptide combinations, as well as on the type of
cytokine secretion pathway (no synergistic effect was detected in the
inhibition of other LPS-induced cytokines such as IL-6 [83]). Regarding
the corresponding molecular mechanism, there are two remarkable
points: (i) the synergistic effect of temporins in the anti-endotoxin
activity inversely correlates with the size of the LPS-carbohydrate
chains, and therefore occurs with LPS having short length saccharidic
portions. (ii) Themolecular basis accounting for this synergism differs
from that underlying the synergism in the microbial killing which in
turn is favoured by LPS with a long polysaccharide region and is linked
to the ability of the peptide oligomers to dissociate upon their binding
to the bacterial OM (see the scheme of Fig. 8).
5. Concluding remarks
The skin of anurans (frogs and toads) constitutes an important
source of biologically active peptides that are used as potential new
pharmaceutical agents. One biological rationale for the existence ofstructurally similar peptides within the same frog species can be
attributed to their ability to synergize in both the antimicrobial and
anti-endotoxin activities in order to protect the animal from a wider
repertoire of infectious microorganisms and/or their septic shock
[84,85]. At present, these ﬁndings have been described only with
peptides derived from amphibian skin, but should be searched also in
other families of AMPs. All together, in addition to their contribution
to the understanding of the defence mechanism of frogs, such studies
should assist in the future development and manufacturing of new
natural-like anti-infective and anti-endotoxin drugs, which are
urgently needed, because of the emergence of resistant pathogens
to conventional antibiotics, as well as because of the high mortality,
particularly among hospitalized patients, owing to septic shock.
Acknowledgments
This work was supported by grants from the Italian Ministero
dell'Università e della Ricerca and Università La Sapienza, Rome.
Y.S. has the Harold S. and Harriet B. Brady Professorial Chair in
Cancer Research.
References
[1] V. Erspamer, Bioactive secretions of the amphibian integument, in: H. Heatwole
(Ed.), Amphibian Biology, 1, Surray Beatty and Sons, Chipping Northon, 1994,
pp. 178–350.
[2] C.L. Bevins, M. Zasloff, Peptides from frog skin, Annu. Rev. Biochem. 59 (1990)
395–414.
1618 M.L. Mangoni, Y. Shai / Biochimica et Biophysica Acta 1788 (2009) 1610–1619[3] M. Simmaco, G. Mignogna, D. Barra, Antimicrobial peptides from amphibian
skin: what do they tell us? Biopolymers 47 (1998) 435–450.
[4] M. Zasloff, Antimicrobial peptides of multicellular organisms, Nature 415 (2002)
389–395.
[5] H.G. Boman, Peptide antibiotics and their role in innate immunity, Annu. Rev.
Immunol. 13 (1995) 61–92.
[6] H.G. Boman, Innate immunity and the normal microﬂora, Immunol. Rev. 173
(2000) 5–16.
[7] A. Mor, K. Hani, P. Nicolas, The vertebrate peptide antibiotics dermaseptins have
overlapping structural features but target speciﬁc microorganisms, J. Biol. Chem.
269 (1994) 31635–31641.
[8] L.A. Rollins-Smith, J.K. Doersam, J.E. Longcore, S.K. Taylor, J.C. Shamblin, C. Carey,
M.A. Zasloff, Antimicrobial peptide defenses against pathogens associated with
global amphibian declines, Dev. Comp. Immunol. 26 (2002) 63–72.
[9] M.L. Mangoni, Temporins, anti-infective peptides with expanding properties,
Cell. Mol. Life Sci. 63 (2006) 1060–1069.
[10] B.W. Gibson, D.Z. Tang, R. Mandrell, M. Kelly, E.R. Spindel, Bombinin-like peptides
with antimicrobial activity from skin secretions of the Asian toad, Bombina
orientalis, J. Biol. Chem. 266 (1991) 23103–23111.
[11] M. Simmaco, D. Barra, F. Chiarini, L. Noviello, P. Melchiorri, G. Kreil, K. Richter, A
family of bombinin-related peptides from the skin of Bombina variegata, Eur. J.
Biochem. 199 (1991) 217–222.
[12] M.L. Mangoni, N. Grovale, A. Giorgi, G. Mignogna, M. Simmaco, D. Barra,
Structure–function relationships in bombinins H, antimicrobial peptides from
Bombina skin secretions, Peptides 21 (2000) 1673–1679.
[13] G. Mignogna, M. Simmaco, G. Kreil, D. Barra, Antibacterial and haemolytic
peptides containing D-alloisoleucine from the skin of Bombina variegata, EMBO J.
12 (1993) 4829–4832.
[14] M. Zasloff, Magainins, a class of antimicrobial peptides from Xenopus skin:
isolation, characterization of two active forms, and partial cDNA sequence of a
precursor, Proc. Natl. Acad. Sci. U. S. A. 84 (1987) 5449–5453.
[15] A. Mor, P. Nicolas, Isolation and structure of novel defensive peptides from frog
skin, Eur. J. Biochem. 219 (1994) 145–154.
[16] A. Mor, M. Amiche, P. Nicolas, Structure, synthesis, and activity of dermaseptin b,
a novel vertebrate defensive peptide from frog skin: relationship with
adenoregulin, Biochemistry 33 (1994) 6642–6650.
[17] N. Morikawa, K. Hagiwara, T. Nakajima, Brevinin-1 and -2, unique antimicrobial
peptides from the skin of the frog, Rana brevipoda porsa, Biochem. Biophys. Res.
Commun. 189 (1992) 184–190.
[18] M. Simmaco, G. Mignogna, D. Barra, F. Bossa, Antimicrobial peptides from skin
secretions of Rana esculenta. Molecular cloning of cDNAs encoding esculentin
and brevinins and isolation of new active peptides, J. Biol. Chem. 269 (1994)
11956–11961.
[19] J. Goraya, Y. Wang, Z. Li, M. O'Flaherty, F.C. Knoop, J.E. Platz, J.M. Conlon, Peptides
with antimicrobial activity from four different families isolated from the skins of
the North American frogs Rana luteiventris, Rana berlandieri and Rana pipiens,
Eur. J. Biochem. 267 (2000) 894–900.
[20] M. Simmaco, G. Mignogna, S. Canofeni, R. Miele, M.L. Mangoni, D. Barra,
Temporins, antimicrobial peptides from the European red frog Rana temporaria,
Eur. J. Biochem. 242 (1996) 788–792.
[21] J.M. Conlon, J. Kolodziejek, N. Nowotny, Antimicrobial peptides from ranid frogs:
taxonomic and phylogenetic markers and a potential source of new therapeutic
agents, Biochim. Biophys. Acta 1696 (2004) 1–14.
[22] Y. Rosenfeld, D. Barra, M. Simmaco, Y. Shai, M.L. Mangoni, A synergism between
temporins toward Gram-negative bacteria overcomes resistance imposed by the
lipopolysaccharide protective layer, J. Biol. Chem. 281 (2006) 28565–28574.
[23] H.V. Westerhoff, M. Zasloff, J.L. Rosner, R.W. Hendler, A. De Waal, A. Vaz Gomes,
P.M. Jongsma, A. Riethorst, D. Juretic, Functional synergism of the magainins
PGLa and magainin-2 in Escherichia coli, tumor cells and liposomes, Eur. J.
Biochem. 228 (1995) 257–264.
[24] M. Simmaco, D. De Biase, C. Severini, M. Aita, G.F. Erspamer, D. Barra, F. Bossa,
Puriﬁcation and characterization of bioactive peptides from skin extracts of Rana
esculenta, Biochim. Biophys. Acta 1033 (1990) 318–323.
[25] J.M. Conlon, Reﬂections on a systematic nomenclature for antimicrobial peptides
from the skins of frogs of the family Ranidae, Peptides 29 (2008) 1815–1819.
[26] A. Argiolas, J.J. Pisano, Isolation and characterization of two new peptides,
mastoparan C and crabrolin, from the venom of the European hornet, Vespa
crabro, J. Biol. Chem. 259 (1984) 10106–10111.
[27] D.P. Clark, S. Durell, W.L. Maloy, M. Zasloff, Ranalexin. A novel antimicrobial
peptide from bullfrog (Rana catesbeiana) skin, structurally related to the
bacterial antibiotic, polymyxin, J. Biol. Chem. 269 (1994) 10849–10855.
[28] M. Amiche, A.A. Seon, T.N. Pierre, P. Nicolas, The dermaseptin precursors: a
protein family with a common preproregion and a variable C-terminal
antimicrobial domain, FEBS Lett. 456 (1999) 352–356.
[29] A.F. Bradbury, D.G. Smyth, Peptide amidation, Trends Biochem. Sci. 16 (1991)
112–115.
[30] D. Wade, J. Silberring, R. Soliymani, S. Heikkinen, I. Kilpelainen, H. Lankinen, P.
Kuusela, Antibacterial activities of temporin A analogs, FEBS Lett. 479 (2000)
6–9.
[31] A.C. Rinaldi, M.L. Mangoni, A. Rufo, C. Luzi, D. Barra, H. Zhao, P.K. Kinnunen, A.
Bozzi, A. Di Giulio, M. Simmaco, Temporin L: antimicrobial, haemolytic and
cytotoxic activities, and effects on membrane permeabilization in lipid vesicles,
Biochem. J. 368 (2002) 91–100.
[32] J.M. Conlon, R. Al-Kharrge, E. Ahmed, H. Raza, S. Galadari, E. Condamine, Effect of
aminoisobutyric acid (Aib) substitutions on the antimicrobial and cytolytic
activities of the frog skin peptide, temporin-1DRa, Peptides 28 (2007) 2075–2080.[33] F. Abbassi, B. Oury, T. Blasco, D. Sereno, G. Bolbach, P. Nicolas, K. Hani, M. Amiche,
A. Ladram, Isolation, characterization and molecular cloning of new temporins
from the skin of the North African ranid Pelophylax saharica, Peptides 29 (2008)
1526–1533.
[34] F. Abbassi, C. Galanth, M. Amiche, K. Saito, C. Piesse, L. Zargarian, K. Hani, P.
Nicolas, O. Lequin, A. Ladram, Solution structure and model membrane
interactions of temporins-SH, antimicrobial peptides from amphibian skin. A
NMR spectroscopy and differential scanning calorimetry study, Biochemistry 47
(2008) 10513–10525.
[35] M.L. Mangoni, J.M. Saugar, M. Dellisanti, D. Barra, M. Simmaco, L. Rivas,
Temporins, small antimicrobial peptides with leishmanicidal activity, J. Biol.
Chem. 280 (2005) 984–990.
[36] V.G. Chinchar, L. Bryan, U. Silphadaung, E. Noga, D. Wade, L. Rollins-Smith,
Inactivation of viruses infecting ectothermic animals by amphibian and piscine
antimicrobial peptides, Virology 323 (2004) 268–275.
[37] D.W. Hoskin, A. Ramamoorthy, Studies on anticancer activities of antimicrobial
peptides, Biochim. Biophys. Acta 1778 (2008) 357–375.
[38] T. Rozek, K.L. Wegener, J.H. Bowie, I.N. Olver, J.A. Carver, J.C. Wallace, M.J. Tyler,
The antibiotic and anticancer active aurein peptides from the Australian Bell
Frogs Litoria aurea and Litoria raniformis the solution structure of aurein 1.2, Eur.
J. Biochem. 267 (2000) 5330–5341.
[39] J. Doyle, C.S. Brinkworth, K.L. Wegener, J.A. Carver, L.E. Llewellyn, I.N. Olver, J.H.
Bowie, P.A. Wabnitz, M.J. Tyler, nNOS inhibition, antimicrobial and anticancer
activity of the amphibian skin peptide, citropin 1.1 and syntheticmodiﬁcations. The
solution structure of a modiﬁed citropin 1.1, Eur. J. Biochem. 270 (2003) 1141–1153.
[40] H.S. Won, M.D. Seo, S.J. Jung, S.J. Lee, S.J. Kang, W.S. Son, H.J. Kim, T.K. Park, S.J.
Park, B.J. Lee, Structural determinants for the membrane interaction of novel
bioactive undecapeptides derived from gaegurin 5, J. Med. Chem. 49 (2006)
4886–4895.
[41] R.A. Cruciani, J.L. Barker, M. Zasloff, H.C. Chen, O. Colamonici, Antibiotic
magainins exert cytolytic activity against transformed cell lines through channel
formation, Proc. Natl. Acad. Sci. U. S. A. 88 (1991) 3792–3796.
[42] R.E. Hancock, A. Rozek, Role of membranes in the activities of antimicrobial
cationic peptides, FEMS Microbiol. Lett. 206 (2002) 143–149.
[43] M.S. Trent, Biosynthesis, transport, and modiﬁcation of lipid A, Biochem. Cell.
Biol. 82 (2004) 71–86.
[44] E.T. Rietschel, T. Kirikae, F.U. Schade, U. Mamat, G. Schmidt, H. Loppnow, A.J.
Ulmer, U. Zahringer, U. Seydel, F. Di Padova, et al., Bacterial endotoxin: molecular
relationships of structure to activity and function, FASEB J. 8 (1994) 217–225.
[45] M.L. Mangoni, N. Papo, D. Barra, M. Simmaco, A. Bozzi, A. Di Giulio, A.C. Rinaldi,
Effects of the antimicrobial peptide temporin L on cell morphology, membrane
permeability and viability of Escherichia coli, Biochem. J. 380 (2004) 859–865.
[46] A. Carotenuto, S. Malﬁ, M.R. Saviello, P. Campiglia, I. Gomez-Monterrey, M.L.
Mangoni, L.M. Gaddi, E. Novellino, P. Grieco, A different molecular mechanism
underlying antimicrobial and hemolytic actions of temporins A and L, J. Med.
Chem. 51 (2008) 2354–2362.
[47] Y. Shai, Mechanism of the binding, insertion and destabilization of phospholipid
bilayer membranes by alpha-helical antimicrobial and cell non-selective
membrane-lytic peptides. Biochim. Biophys. Acta 1462 (1999) 55–70.
[48] K.A. Henzler Wildman, D.K. Lee, A. Ramamoorthy, Mechanism of lipid bilayer
disruption by the human antimicrobial peptide, LL-37, Biochemistry 42 (2003)
6545–6558.
[49] A. Ramamoorthy, S. Thennarasu, A. Tan, D.K. Lee, C. Clayberger, A.M. Krensky, Cell
selectivity correlates with membrane-speciﬁc interactions: a case study on the
antimicrobial peptide G15 derived from granulysin, Biochim. Biophys. Acta 1758
(2006) 154–163.
[50] A. Ramamoorthy, S. Thennarasu, A. Tan, K. Gottipati, S. Sreekumar, D.L. Heyl, F.Y.
An, C.E. Shelburne, Deletion of all cysteines in tachyplesin I abolishes hemolytic
activity and retains antimicrobial activity and lipopolysaccharide selective
binding, Biochemistry 45 (2006) 6529–6540.
[51] J.P. Powers, A. Tan, A. Ramamoorthy, R.E. Hancock, Solution structure and
interaction of the antimicrobial polyphemusins with lipid membranes,
Biochemistry 44 (2005) 15504–15513.
[52] Y. Rosenfeld, N. Papo, Y. Shai, Endotoxin (lipopolysaccharide) neutralization by
innate immunity host-defense peptides. Peptide properties and plausible modes
of action, J. Biol. Chem. 281 (2006) 1636–1643.
[53] S. Sinha, T. Shimada, T. Ramamurthy, S.K. Bhattacharya, S. Yamasaki, Y. Takeda,
G.B. Nair, Prevalence, serotype distribution, antibiotic susceptibility and genetic
proﬁles of mesophilic Aeromonas species isolated from hospitalized diarrhoeal
cases in Kolkata, India, J. Med. Microbiol. 53 (2004) 527–534.
[54] L.P. Deodhar, K. Saraswathi, A. Varudkar, Aeromonas spp. and their association
with human diarrheal disease, J. Clin. Microbiol. 29 (1991) 853–856.
[55] T. Yamamoto, T. Ishii, M. Sanaka, M. Saitoh, Y. Kuyama, Ileal ulcers due to
Aeromonas hydrophilia infection, J. Clin. Gastroenterol. 38 (2004) 911.
[56] A.K. Marr, W.J. Gooderham, R.E. Hancock, Antibacterial peptides for therapeutic
use: obstacles and realistic outlook, Curr. Opin. Pharmacol. 6 (2006) 468–472.
[57] G.S. Martin, D.M. Mannino, S. Eaton, M. Moss, The epidemiology of sepsis in the
United States from 1979 through 2000, N. Engl. J. Med. 348 (2003) 1546–1554.
[58] E.T. Rietschel, H. Brade, O. Holst, L. Brade, S. Muller-Loennies, U. Mamat, U.
Zahringer, F. Beckmann, U. Seydel, K. Brandenburg, A.J. Ulmer, T. Mattern, H.
Heine, J. Schletter, H. Loppnow, U. Schonbeck, H.D. Flad, S. Hauschildt, U.F.
Schade, F. Di Padova, S. Kusumoto, R.R. Schumann, Bacterial endotoxin: chemical
constitution, biological recognition, host response, and immunological detox-
iﬁcation, Curr. Top. Microbiol. Immunol. 216 (1996) 39–81.
[59] F.X. Zhang, C.J. Kirschning, R. Mancinelli, X.P. Xu, Y. Jin, E. Faure, A. Mantovani,
M. Rothe, M. Muzio, M. Arditi, Bacterial lipopolysaccharide activates nuclear
1619M.L. Mangoni, Y. Shai / Biochimica et Biophysica Acta 1788 (2009) 1610–1619factor-kappaB through interleukin-1 signaling mediators in cultured human
dermal endothelial cells and mononuclear phagocytes, J. Biol. Chem. 274 (1999)
7611–7614.
[60] M.A. Dobrovolskaia, S.N. Vogel, Toll receptors, CD14, and macrophage activation
and deactivation by LPS, Microbes Infect. 4 (2002) 903–914.
[61] Y. Kubo, N. Fukuishi, M. Yoshioka, Y. Kawasoe, S. Iriguchi, N. Imajo, Y. Yasui, N.
Matsui, M. Akagi, Bacterial components regulate the expression of Toll-like
receptor 4 on human mast cells, Inﬂamm. Res. 56 (2007) 70–75.
[62] K. Gee, M. Kozlowski, A. Kumar, Tumor necrosis factor-alpha induces functionally
active hyaluronan-adhesive CD44 by activating sialidase through p38 mitogen-
activated protein kinase in lipopolysaccharide-stimulated human monocytic
cells, J. Biol. Chem. 278 (2003) 37275–37287.
[63] S. Mukhopadhyay, J. Herre, G.D. Brown, S. Gordon, The potential for Toll-like
receptors to collaborate with other innate immune receptors, Immunology 112
(2004) 521–530.
[64] C.A. Dinarello, Cytokines as mediators in the pathogenesis of septic shock, Curr.
Top. Microbiol. Immunol. 216 (1996) 133–165.
[65] J.M. Prins, E.J. Kuijper, M.L. Mevissen, P. Speelman, S.J. van Deventer, Release of
tumor necrosis factor alpha and interleukin 6 during antibiotic killing of Escher-
ichia coli in whole blood: inﬂuence of antibiotic class, antibiotic concentration,
and presence of septic serum, Infect. Immun. 63 (1995) 2236–2242.
[66] B. Byl, P. Clevenbergh, A. Kentos, F. Jacobs, A. Marchant, J.L. Vincent, J.P. Thys,
Ceftazidime- and imipenem-induced endotoxin release during treatment of
Gram-negative infections, Eur. J. Clin. Microbiol. Infect. Dis. 20 (2001) 804–807.
[67] J. Cohen, The immunopathogenesis of sepsis, Nature 420 (2002) 885–891.
[68] D.C. Angus, R.S. Wax, Epidemiology of sepsis: an update, Crit. Care Med. 29
(2001) S109–116.
[69] M.G. Scott, A.C. Vreugdenhil, W.A. Buurman, R.E. Hancock, M.R. Gold, Cutting
edge: cationic antimicrobial peptides block the binding of lipopolysaccharide
(LPS) to LPS binding protein, J. Immunol. 164 (2000) 549–553.
[70] R. Jerala, M. Porro, Endotoxin neutralizing peptides, Curr. Top. Med. Chem. 4
(2004) 1173–1184.
[71] R.E. Hancock, G. Diamond, The role of cationic antimicrobial peptides in innate
host defences, Trends Microbiol. 8 (2000) 402–410.
[72] M.G. Scott, H. Yan, R.E. Hancock, Biological properties of structurally related
alpha-helical cationic antimicrobial peptides, Infect. Immun. 67 (1999)
2005–2009.
[73] N. Mookherjee, L.M. Rehaume, R.E. Hancock, Cathelicidins and functional
analogues as antisepsis molecules, Expert Opin. Ther. Targets 11 (2007)
993–1004.
[74] E. Soravia, G. Martini, M. Zasloff, Antimicrobial properties of peptides from
Xenopus granular gland secretions, FEBS Lett. 228 (1988) 337–340.
[75] I. Nagaoka, S. Hirota, S. Yomogida, A. Ohwada, M. Hirata, Synergistic actions of
antibacterial neutrophil defensins and cathelicidins, Inﬂamm. Res. 49 (2000)
73–79.
[76] X. Lauth, J.J. Babon, J.A. Stannard, S. Singh, V. Nizet, J.M. Carlberg, V.E. Ostland,
M.W. Pennington, R.S. Norton, M.E. Westerman, Bass hepcidin synthesis,
solution structure, antimicrobial activities and synergism, and in vivo hepatic
response to bacterial infections, J. Biol. Chem. 280 (2005) 9272–9282.
[77] M. Nishida, Y. Imura, M. Yamamoto, S. Kobayashi, Y. Yano, K. Matsuzaki,
Interaction of a magainin-PGLa hybrid peptide with membranes: insight into the
mechanism of synergism, Biochemistry 46 (2007) 14284–14290.
[78] T. Hara, Y. Mitani, K. Tanaka, N. Uematsu, A. Takakura, T. Tachi, H. Kodama, M.
Kondo, H. Mori, A. Otaka, F. Nobutaka, K. Matsuzaki, Heterodimer formation
between the antimicrobial peptides magainin 2 and PGLa in lipid bilayers: a
cross-linking study, Biochemistry 40 (2001) 12395–12399.
[79] K. Matsuzaki, Y. Mitani, K.Y. Akada, O. Murase, S. Yoneyama, M. Zasloff, K.
Miyajima, Mechanism of synergism between antimicrobial peptides magainin 2
and PGLa, Biochemistry 37 (1998) 15144–15153.
[80] M.L. Mangoni, R.F. Epand, Y. Rosenfeld, A. Peleg, D. Barra, R.M. Epand, Y. Shai,
Lipopolysaccharide, a key molecule involved in the synergism between
temporinsin inhibiting bacterial growth and in endotoxin neutralization, J. Biol.
Chem. 283 (2008) 22907–22917.
[81] Y. Rosenfeld, H.G. Sahl, Y. Shai, Parameters involved in antimicrobial and
endotoxin detoxiﬁcation activities of antimicrobial peptides, Biochemistry 47
(2008) 6468–6478.
[82] P. Li, T. Wohland, B. Ho, J.L. Ding, Perturbation of Lipopolysaccharide (LPS)
Micelles by Sushi 3 (S3) antimicrobial peptide. The importance of an
intermolecular disulﬁde bond in S3 dimer for binding, disruption, and
neutralization of LPS, J. Biol. Chem. 279 (2004) 50150–50156.[83] N. Hirohashi, D.C. Morrison, Low-dose lipopolysaccharide (LPS) pretreatment of
mouse macrophages modulates LPS-dependent interleukin-6 production in
vitro, Infect. Immun. 64 (1996) 1011–1015.
[84] I. Berczi, L. Bertok, T. Bereznai, Comparative studies on the toxicity of Escherichia
coli lipopolysaccharide endotoxin in various animal species, Can. J. Microbiol. 12
(1966) 1070–1071.
[85] D.B. Iliev, J.C. Roach, S. Mackenzie, J.V. Planas, F.W. Goetz, Endotoxin recognition:
in ﬁsh or not in ﬁsh? FEBS Lett. 579 (2005) 6519–6528.
[86] D. Lewis, Antimicrobial resistance surveillance: methods will depend on
objectives, J. Antimicrob. Chemother. 49 (2002) 3–5.
[87] Y. Lu, J. Li, H. Yu, X. Xu, J. Liang, Y. Tian, D. Ma, G. Lin, G. Huang, R. Lai, Two families
of antimicrobial peptides with multiple functions from skin of rufous-spotted
torrent frog, Amolops loloensis, Peptides 27 (2006) 3085–3091.
[88] M.F. Ali, K.R. Lips, F.C. Knoop, B. Fritzsch, C. Miller, J.M. Conlon, Antimicrobial
peptides and protease inhibitors in the skin secretions of the crawﬁsh frog, Rana
areolata, Biochim. Biophys. Acta 1601 (2002) 55–63.
[89] J.M. Conlon, A. Sonnevend, C. Davidson, A. Demandt, T. Jouenne, Host-defense
peptides isolated from the skin secretions of the Northern red-legged frog Rana
aurora aurora, Dev. Comp. Immunol. 29 (2005) 83–90.
[90] J.M. Conlon, A. Sonnevend, M. Patel, C. Davidson, P.F. Nielsen, T. Pal, L.A. Rollins-
Smith, Isolation of peptides of the brevinin-1 family with potent candidacidal
activity from the skin secretions of the frog Rana boylii, J. Pept. Res. 62 (2003)
207–213.
[91] T. Halverson, Y.J. Basir, F.C. Knoop, J.M. Conlon, Puriﬁcation and characterization
of antimicrobial peptides from the skin of the North American green frog Rana
clamitans, Peptides 21 (2000) 469–476.
[92] M.F. Ali, F.C. Knoop, H. Vaudry, J.M. Conlon, Characterization of novel
antimicrobial peptides from the skins of frogs of the Rana esculenta complex,
Peptides 24 (2003) 955–961.
[93] J.B. Kim, T. Halverson, Y.J. Basir, J. Dulka, F.C. Knoop, P.W. Abel, J.M. Conlon,
Puriﬁcation and characterization of antimicrobial and vasorelaxant peptides
from skin extracts and skin secretions of the North American pig frog Rana grylio,
Regul. Pept. 90 (2000) 53–60.
[94] J. Zhou, S. McClean, A. Thompson, Y. Zhang, C. Shaw, P. Rao, A.J. Bjourson,
Puriﬁcation and characterization of novel antimicrobial peptides from the skin
secretion of Hylarana guentheri, Peptides 27 (2006) 3077–3084.
[95] J.M. Conlon, L. Coquet, J. Leprince, T. Jouenne, H. Vaudry, J. Kolodziejek, N.
Nowotny, C.R. Bevier, P.E. Moler, Peptidomic analysis of skin secretions from
Rana heckscheri and Rana okaloosae provides insight into phylogenetic relation-
ships among frogs of the Aquarana species group, Regul. Pept. 138 (2007)
87–93.
[96] T. Isaacson, A. Soto, S. Iwamuro, F.C. Knoop, J.M. Conlon, Antimicrobial peptides
with atypical structural features from the skin of the Japanese brown frog Rana
japonica, Peptides 23 (2002) 419–425.
[97] J.B. Kim, S. Iwamuro, F.C. Knoop, J.M. Conlon, Antimicrobial peptides from the
skin of the Japanese mountain brown frog, Rana ornativentris, J. Pept. Res. 58
(2001) 349–356.
[98] Y.J. Basir, F.C. Knoop, J. Dulka, J.M. Conlon, Multiple antimicrobial peptides and
peptides related to bradykinin and neuromedin N isolated from skin secretions
of the pickerel frog, Rana palustris, Biochim. Biophys. Acta 1543 (2000)
95–105.
[99] J.M. Conlon, A. Sonnevend, M. Patel, K. Al-Dhaheri, P.F. Nielsen, J. Kolodziejek, N.
Nowotny, S. Iwamuro, T. Pal, A family of brevinin-2 peptides with potent activity
against Pseudomonas aeruginosa from the skin of the Hokkaido frog, Rana pirica,
Regul. Pept. 118 (2004) 135–141.
[100] C.R. Bevier, A. Sonnevend, J. Kolodziejek, N. Nowotny, P.F. Nielsen, J.M. Conlon,
Puriﬁcation and characterization of antimicrobial peptides from the skin
secretions of the mink frog (Rana septentrionalis), Comp. Biochem. Physiol., C
Toxicol. Pharmacol. 139 (2004) 31–38.
[101] J.M. Conlon, A. Sonnevend, M. Patel, V. Camasamudram, N. Nowotny, E. Zilahi, S.
Iwamuro, P.F. Nielsen, T. Pal, A melittin-related peptide from the skin of the
Japanese frog, Rana tagoi, with antimicrobial and cytolytic properties, Biochem.
Biophys. Res. Commun. 306 (2003) 496–500.
[102] J.M. Conlon, B. Abraham, A. Sonnevend, T. Jouenne, P. Cosette, J. Leprince, H.
Vaudry, C.R. Bevier, Puriﬁcation and characterization of antimicrobial peptides
from the skin secretions of the carpenter frog Rana virgatipes (Ranidae,
Aquarana), Regul. Pept. 131 (2005) 38–45.
[103] T. Chen, M. Zhou, P. Rao, B. Walker, C. Shaw, The Chinese bamboo leaf odorous
frog (Rana (Odorrana) versabilis) and North American Rana frogs share the same
families of skin antimicrobial peptides, Peptides 27 (2006) 1738–1744.
